🔬 Selected Publications
Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial Nature Communications, 2025 https://www.nature.com/articles/s41467-025-61691-4
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma Nature Communications, 2024 https://www.nature.com/articles/s41467-024-49842-5
👋 About Me
I’m a Bioinformatics Scientist specializing in cancer genomics, currently working as a Bioinformatics Researcher at the Leicester Cancer Research Centre. Previously, I completed my PhD within the Mesothelioma Research Program, where I focused on immunogenomic mechanisms and pathway-level analyses of tumour evolution.
My interests span RNA-seq, pathway inference (GSEA/PROGENy/ssGSEA), causal modelling, and immunotherapy response prediction.
Outside of research, I love playing music, performing live, and spending time snowboarding.